Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Gronwald

Showing results (61-70 of 307) with videos related to

Pageof 31
Sort By:
Hereditary Cancer in Clinical Practice|March 29, 2019
Selected features of breast and peritoneal cancers diagnosed in <i>BRCA1</i> carriers after risk-reducing salpingo-oophorectomyJanusz Menkiszak, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, et al.
BMC Cancer|August 31, 2021
Genetic predisposition to male breast cancer in PolandMarek Szwiec, Joanna Tomiczek-Szwiec, Wojciech Kluźniak, et al.
Cancers|February 26, 2025
<i>BRCA1</i> and <i>BRCA2</i> Mutations in Polish Women with Ductal Carcinoma In SituSylwia Feszak, Igor Jarosław Feszak, Wojciech Kluźniak, et al.
European Journal of Human Genetics : EJHG|December 3, 2003
A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancerAnna Jakubowska, Rodney Scott, Janusz Menkiszak, et al.
The Journal of Molecular Diagnostics : JMD|December 17, 2009
Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patientsDagmara Dymerska, Pablo Serrano-Fernández, Janina Suchy, et al.
International Journal of Cancer|November 13, 2004
Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridizationJacek Gronwald, Anna Jauch, Cezary Cybulski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriersJoanne Kotsopoulos, Beth Karlan, Jacek Gronwald, et al.
Gynecologic Oncology|March 19, 2017
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Jacob McGee, Vasily Giannakeas, Beth Karlan, et al.
Cancer Research|February 12, 2005
CDKN2A common variants and their association with melanoma risk: a population-based studyTadeusz Debniak, Rodney J Scott, Tomasz Huzarski, et al.
Hereditary Cancer in Clinical Practice|January 22, 2015
Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC familiesTadeusz Dębniak, Tomasz Gromowski, Rodney J Scott, et al.
Pageof 31

Showing results (61-70 of 307) with videos related to

Sort By:
Pageof 31
Hereditary Cancer in Clinical Practice|March 29, 2019
Selected features of breast and peritoneal cancers diagnosed in <i>BRCA1</i> carriers after risk-reducing salpingo-oophorectomyJanusz Menkiszak, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, et al.
BMC Cancer|August 31, 2021
Genetic predisposition to male breast cancer in PolandMarek Szwiec, Joanna Tomiczek-Szwiec, Wojciech Kluźniak, et al.
Cancers|February 26, 2025
<i>BRCA1</i> and <i>BRCA2</i> Mutations in Polish Women with Ductal Carcinoma In SituSylwia Feszak, Igor Jarosław Feszak, Wojciech Kluźniak, et al.
European Journal of Human Genetics : EJHG|December 3, 2003
A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancerAnna Jakubowska, Rodney Scott, Janusz Menkiszak, et al.
The Journal of Molecular Diagnostics : JMD|December 17, 2009
Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patientsDagmara Dymerska, Pablo Serrano-Fernández, Janina Suchy, et al.
International Journal of Cancer|November 13, 2004
Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridizationJacek Gronwald, Anna Jauch, Cezary Cybulski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriersJoanne Kotsopoulos, Beth Karlan, Jacek Gronwald, et al.
Gynecologic Oncology|March 19, 2017
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Jacob McGee, Vasily Giannakeas, Beth Karlan, et al.
Cancer Research|February 12, 2005
CDKN2A common variants and their association with melanoma risk: a population-based studyTadeusz Debniak, Rodney J Scott, Tomasz Huzarski, et al.
Hereditary Cancer in Clinical Practice|January 22, 2015
Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC familiesTadeusz Dębniak, Tomasz Gromowski, Rodney J Scott, et al.
Pageof 31